Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Genetics and hormones cause hair loss; finasteride treats it safely.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Finasteride effectively treats male hair loss, improving growth and density.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.